Partner With Prostaid Calgary
Prostaid Calgary is the oldest and primary prostate cancer support group in Calgary, having been formed in 1933 Celebrating over […]
March 2026
Includes: New characteristics of aggressive prostate cancer identified, how to treat recurring prostate cancer, apalutamide vs. darolutamide in mCSPC,
Monthly Supporter
Your Monthly Gift Brings Hope and Support to Families Facing Prostate Cancer PROSTAID Calgary is a community of men, families, […]
Introduction to PARP-Inhibitors and their role in Cancer Treatment
Dr. Geoffrey Gotto, Urologic Oncologist at the Southern Alberta Institute of Urology, joins us again to explain PARP inhibitors and their importance in modern treatment of cancer cells.
February 2026
Includes: Spotlighting the Top 10 FDA Oncology Approvals in 2025, CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction,
January 2026
Includes: Prostate cancer cells thrive in bone tissue, Top 10 Urology Times prostate cancer articles of 2025, Reversing treatment resistance in prostate cancer,